STEM CELL THERAPY
The future of healthcare is a personalized medicine. This means an individual approach with specific treatment for each person, depending most of all on person’s genomics, but also several other factors.
Previous medical approaches have been based upon a policy of “one size fits all”, applying the same treatments to those with the same diseases. However, this has many limitations as there are a whole range of disease contributing factors, including genetics and environment, which affect the efficacy of certain medications. There are many advantages to the applications of personalized medicine within healthcare. Read more
The therapy with person’s individual stem cells is the highest form of personalized medical application. It is natural and matches completely with the body. This kind of treatment method has been used successfully in everyday practice for more than 20 years. It has helped to cure diseases or even save the life. Medicine is developing fast and soon it will be possible to cure many more diseases or grow new tissues in the body by using the stem cells. Currently there are over 300 therapies in clinical trial or late stages of research using umbilical cord stem cells. Many of these will become a reality in the lifetime of a child born today.
Umbilical cord is the best source of stem cells, but this valuable material is usually thrown away after birth. There are two types of stem cells, which can be obtained from the umbilical cord: blood and tissue stem cells.
In order to have the stem cells for future usage, they have to be taken straight after birth and stored in the special cell bank at a very low temperature. They can be used for a child if needed or later in the life. Those private stem cells will match 100% with the child him/herself, but with good probability they match also with the siblings and the parents.
Umbilical cord blood stem cells
The umbilical cord blood stem cells are called haematopoeitic stem cells (HSCs). have more potential to develop into different blood cells. The first successful treatment with stem cells was done already in 1988 for Fancon’i anemia (1). From this time the list of diseases treated with stem cells has increased enormously. It is used for many blood diseases, leucaemia and lymphoma among them, for immunodeficiency disorders, for cancers etc. Umbilical cord blood stem cells are used as a standard therapy for more 85 diseases. Read more
There are many clinical studies with cord blood stem cells (HSC) going on in the world. Good results have already been seen in treatment of diabetes, HIV, osteoarthritis, autism, cerebral palsy and on many other diagnosis.
Umbilical cord tissue stem cells
- Newborn’s umbilical cord tissue contains the highest amount of mesenchymal stem cells (MSCs). Those cells have been discovered not very long ago, but have gained a lot of attention, as having great potential to differentiate into multi-lineage cells. Multi-lineage potential, immunomodulation and secretion of anti-inflammatory molecules makes MSCs an effective tool in the treatment of chronic diseases. Those stem cells (MSCs) can make several types of cells belonging to our skeletal tissues, such as cartilage, bone, fat and other tissues. From the treatment with MCSs may receive good benefit patients with diabetes, Parkinson’s and Alzheimer disease, with heart and liver diseases, joint problems, traumas and many others. MSCs are currently used in human clinical trials, and have demonstarted good results already.
Detailed overview of the diseases which are studied in the clinical trial with MSCs or HSCs can be found here
“ Gluckman, E., et al. “Hematopoietic Reconstitution in a Patient with Fanconi’s Anemia by Means of Umbilical-cord Blood from an HLA-identical Sibling.” Diss. Bone Marrow Transplant Unit, Hôpital Saint-Louis, Paris, France, n.d. Abstract. National Center for Biotechnology Information. U.S.
National Library of Medicine, n.d. Web. 27 May 2014. <http://www.ncbi.nlm.nih.gov/pubmed/2571931>.”